People | June 29, 2022
DTx Pharma appoints Peter Condon as Chief Business Officer
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Tislelizumab is now approved in nine indications in China
Company hires life science veteran Jessica Cao to join management team
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
Subscribe To Our Newsletter & Stay Updated
